drospirenone and ethinyl estradiol combination has been researched along with spironolactone in 2 studies
| Studies (drospirenone and ethinyl estradiol combination) | Trials (drospirenone and ethinyl estradiol combination) | Recent Studies (post-2010) (drospirenone and ethinyl estradiol combination) | Studies (spironolactone) | Trials (spironolactone) | Recent Studies (post-2010) (spironolactone) |
|---|---|---|---|---|---|
| 130 | 51 | 102 | 7,222 | 960 | 1,923 |
| Protein | Taxonomy | drospirenone and ethinyl estradiol combination (IC50) | spironolactone (IC50) |
|---|---|---|---|
| Chain A, Mineralocorticoid receptor | Homo sapiens (human) | 0.049 | |
| Chain A, Mineralocorticoid receptor | Homo sapiens (human) | 0.049 | |
| Estrogen receptor | Homo sapiens (human) | 5.702 | |
| Glucocorticoid receptor | Homo sapiens (human) | 4.0745 | |
| Progesterone receptor | Homo sapiens (human) | 1.675 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.9025 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0315 | |
| Androgen receptor | Homo sapiens (human) | 0.3585 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.406 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.9025 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.9025 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.9025 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 6.92 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
| Bayraktar, M; Cinar, N; Harmanci, A; Yildiz, BO | 1 |
2 other study(ies) available for drospirenone and ethinyl estradiol combination and spironolactone
| Article | Year |
|---|---|
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
Topics: Adult; Androstenes; C-Reactive Protein; Cholesterol, HDL; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Polycystic Ovary Syndrome; Prospective Studies; Reproductive Control Agents; Spironolactone; Testosterone; Triglycerides; Young Adult | 2013 |